Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Conferences
Guide to authors
Online submissionOnline submission
Permissions
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
naturereprints
About this site
For librarians
 
NPG Resources
Bioentrepreneur
Nature Reviews Drug Discovery
Nature
Nature Medicine
Nature Genetics
Nature Reviews Genetics
Nature Methods
Nature Chemical Biology
news@nature.com
Clinical Pharmacology & Therapeutics
Nature Conferences
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Research Article
Nature Biotechnology  14, 1570 - 1573 (1996)
doi:10.1038/nbt1196-1570

Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types

Thomas J. Wickham1, *, Peter W. Roelvink1, Douglas E. Brough1 & Imre Kovesdi1

  1Gen Vec Inc., 12111 Parklawn Dr., Rockville, MD 20854.

  *e-mail: wickham@genvec.com

Adenovirus (Ad) is used as a vector for gene delivery in therapies involving genetic disease, vascular disease, and cancer. The first step for efficient gene transfer is effective virus binding to the target cells. We have found that Ad-mediated gene delivery to multiple cell types is much less efficient compared to epithelial-derived cells. Low gene delivery to nonepithelial cell types was directly correlated to a deficiency of the cellular receptor which mediates Ad binding. To overcome this inefficiency we constructed a new virus, AdPK, that contains a heparin-binding domain that targets the virus to broadly expressed, heparan-containing cellular receptors. AdPK delivers genes to multiple cell types at markedly higher efficiencies than unmodified Ad. Viruses with enhanced attachment characteristics significantly improve gene transfer efficiency and may expand the tissues amenable to efficient Ad-mediated gene therapy.

REFERENCES
  1. Rosenfeld, M.A., Yoshimura, K., Trapnell, B.C., Yoneyama, K., Rosenthal, E.R., Dalemans, W. et al. 1992. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68: 143−155. | Article | PubMed  | ISI | ChemPort |
  2. Quantin, B., Perricaudet, L.D., Tajbakhsh, S. and Mandel, J.L. 1992. Adenovirus as an expression vector in muscle cells in vivo. Proc. Natl. Acad. Sci. USA 89: 2581−2584. | PubMed  | ChemPort |
  3. Lemarchand, P., Jaffe, H.A., Danel, C., Cid, M.C., Kleinman, H.K., Stratford-Perricaudet, L.D. et al. 1992. Adenovirus-mediated transfer of a recombinant human alpha 1-antitrypsin cDNA to human endothelial cells. Proc. Natl. Acad. Sci. USA 89: 6482−6486. | PubMed  | ChemPort |
  4. Anton, M. and Graham, F.L. 1995. Site-specific recombination mediated by an adenovirus vector expressing the ere recombinase protein: a molecular switch for control of gene expression. J. Virol. 69: 4600−4606. | PubMed  | ISI | ChemPort |
  5. Le Gal La Salle, G., Robert, J.J., Berrard, S., Ridoux, V., Stratford-Perricaudet, L.D., Perricaudet, M. et al. 1993. An adenovirus vector for gene transfer into neurons and glia in the brain. Science 259: 988−990. | PubMed  | ChemPort |
  6. Grubb, B.R., Pickles, R.J., Ye, H., Yankaskas, J.R., Vick, R.N., Engelhardt, J.F. et al. 1994. Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature 371: 802−806. | Article | PubMed  | ISI | ChemPort |
  7. Dupuit, F., Zahm, J.-M., Pierrot, D., Brezillon, S., Bonnet, N., Imler, J.-L. et al. 1995. Regenerating cells in human airway surface epithelium represent preferential targets for recombinant adenovirus. Human Gene Therapy 6: 1185−1193. | PubMed  | ISI | ChemPort |
  8. Acsadi, G., Jani, A., Huard, J., Blaschuk, K., Massie, B., Holland, P. et al. 1994. Cultured human myoblasts and myotubes show markedly different transducibility by replication-defective adenovirus recombinants. Gene Ther. 1: 338−340. | PubMed  | ISI | ChemPort |
  9. Acsadi, G., Lochmuller, H., Jani, A., Huard, J., Massie, B., Prescott, S. et al. 1996. Dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer. Hum. Gene Ther. 7: 129−140. | PubMed  | ISI | ChemPort |
  10. March, K.L., Madison, J.E. and Trapnell, B.C. 1995. Pharmocokinetics of adenoviral vector-mediated gene delivery to vascular smooth muscle cells: modulation by poloxamer 407 and implications for cardiovascular gene therapy. Hum. Gene Ther. 6: 41−53. | PubMed  | ISI | ChemPort |
  11. Heikkila, P., Parpala, T., Lukkarinen, O., Weber, M. and Tryggvason, K. 1996. Adenovirus-mediated gene transfer into kidney glomeruli using an exvivo and in vivo kidney perfusion system—first steps towards gene therapy of Alport syndrome. Gene Ther. 3: 21−27. | PubMed  | ISI | ChemPort |
  12. Huang, S., Endo, R.I. and Nemerow, G.R. 1995. Upregulation of integrins alphavbeta3 and alphavbeta5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery. J. Virol. 69: 2257−2263. | PubMed  | ISI | ChemPort |
  13. Wattel, E., Vanrumbeke, M., Abina, M.A., Cambier, N., Preudhomme, C., Haddada, H. et al. 1996. Differential efficacy of adenoviral mediated gene transfer into cells from hematological cell lines and fresh hematological malignancies. Leukemia 10: 171−174. | PubMed  | ISI | ChemPort |
  14. Pickles, R.J., Barker, P.M., Ye, H. and Boucher, R.C. 1996. Efficient adenovirus-mediated gene transfer to basal but not columnar cells of cartilaginous airway epithelia. Hum. Gene Ther. 7: 921−931. | PubMed  | ISI | ChemPort |
  15. Philipson, L., Lonberg-Holm, K. and Pettersson, U. 1968. Virus-receptor interaction in an adenovirus system. J. Virol. 2: 1064−1075. | PubMed  | ISI | ChemPort |
  16. Wickham, T.J., Mathias, P., Cheresh, D.A. and Nemerow, G.R. 1993. Integrins alphav7beta;3 and alphavbeta5 promote adenovirus internalization but not virus attachment. Cell 73: 309−319. | Article | PubMed  | ISI | ChemPort |
  17. Defer, C., Belin, M.T., Caillet-Boudin, M.L. and Boulanger, P. 1990. Human adenovirus-host cell interactions: comparative study with members of subgroups B and C. J. Virol. 64: 3661−3673. | PubMed  | ISI | ChemPort |
  18. Stevenson, S.C., Rollence, M., White, B., Weaver, L. and McClelland, A. 1995. Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain. J. Virol. 69: 2850−2857. | PubMed  | ISI | ChemPort |
  19. Mathias, P., Wickham, T., Moore, M. and Nemerow, G. 1994. Multiple adenovirus serotypes use alphav integrins for infection. J. Virol. 68: 6811−6814. | PubMed  | ISI | ChemPort |
  20. Jalkanen, M., Jalkanen, S. and Bernfield, M. 1991. Binding of extracellular effector molecules by cell surface proteoglycans, pp. 1−30 in Receptors for extracellular matrix. McDonald, J.A. and Mecham, R.P. (eds.). Academic Press, New York.
  21. Michael, S.I., Hong, J.S., Curiel, D.T. and Engler, J.A. 1995. Addition of a short peptide ligand to the adenovirus fiber protein. Gene Ther. 2: 660−668. | PubMed  | ISI | ChemPort |
  22. Wickham, T.J., Carrion, M.E. and Kovesdi, I. 1995. Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs. Gene Ther. 2: 750−756. | PubMed  | ISI | ChemPort |
  23. Wickham, T.J., Segal, D.M., Roelvink, P.W., Carrion, M.E., Lizonova, A., Lee, G.M. et al. 1996. Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies. J. Virol. 70: 6831−6838. | PubMed  | ISI | ChemPort |
  24. Chroboczek, J. and Jacrot, B. 1987. The sequence of adenovirus fiber: similarities and differences between serotypes 2 and 5. Virology 161: 549−554. | Article | PubMed  | ISI | ChemPort |
 Top
 Top
Abstract
Previous | Next
Table of contents
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

  • Fast Growth of Transformed Soybean Shoots

    • Deadline: Jul 15 2009
    • Reward: $10,000 USD

    A method for accelerating growth of soybean shoots is desired.

  • Corrosion Inhibitor

    • Deadline: Aug 19 2009
    • Reward: $10,000 USD

    The Seeker is looking for inhibitors of corrosion. This Challenge requires only a written descripti...

naturejobs

References
Export citation
Export references
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Biotechnology
ISSN: 1087-0156
EISSN: 1546-1696
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | Conferences | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©1996 Nature Publishing Group | Privacy policy